RxNews Recap for Wednesday 11-11-09 Print E-mail
By Mary Davila   
Wednesday, 11 November 2009 21:24

Below is a list of the companies that made news in the healthcare sector on Wednesday, November 11, 2009.



Biotech investors interested in seeing more details about these companies and a full list of their related stories can do so by typing the stock ticker symbol into the Stock Quotes box on the right side of the page.

AVANIR Pharmaceuticals, Inc. (NASDAQ:AVNR) announced the Company will present at the Lazard Capital Markets 6th Annual Healthcare Conference on Wednesday, November 18th at 3:15 p.m. Eastern time (12:15 p.m. Pacific time) at the St. Regis in New York.

Adamis Pharmaceuticals Corporation (OTC:ADMP), announced it’s wholly owned subsidiary, Adamis Labs has now secured distribution contracts and initial stocking orders from the three major wholesalers of prescription drugs in the U.S.

Alexion Pharmaceuticals, Inc. (Nasdaq:ALXN) announced Dr. Leonard Bell, Chief Executive Officer of Alexion Pharmaceuticals, will present at Lazard Capital Markets 6th Annual Healthcare Conference in New York City at 10:00 a.m. ET on Wednesday, November 18, 2009.

Bruker Corporation (NASDAQ:BRKR) announced it will present at the Lazard Capital Markets 6th Annual Healthcare Conference on Tuesday, November 17, 2009, at 10:55 AM Eastern Standard Time in New York City.

Covidien (NYSE:COV) will present at the Lazard Capital Markets 6th Annual Healthcare Conference in New York on Wednesday, November 18, 2009.

Curis, Inc. (NASDAQ:CRIS), a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, announced the Company will be presenting at the Lazard Capital Markets 6th Annual Healthcare Conference at 3:45 p.m. EST on November 18, 2009, in New York City.

Enzo Biochem, Inc. (NYSE:ENZ), a leading vertically integrated clinical lab, life sciences and therapeutic biotechnology company, announced Barry Weiner, President, and David Goldberg, Vice President, Corporate Development, will be presenting at the Lazard Capital Markets 6th Annual Healthcare Conference on Tuesday, November 17, 2009 at 3:40 PM at The St. Regis Hotel in New York, N.Y.

IMS Health (NYSE: RX), the world’s leading provider of market intelligence to the pharmaceutical and healthcare industries, announced the upcoming launch of IMS Oncology QuantifierTM, a comprehensive, clinically rich analytical tool that enables the company’s clients to assess treatment opportunities and guide commercial decisions in the $48 billion global oncology market.

ImmunoGen, Inc. (Nasdaq:IMGN), a biotechnology company that develops targeted anticancer products, announced Howard Pien was elected to its Board of Directors at today’s Annual Meeting of Shareholders.

LecTec Corporation (OTC:LECT) announced it has reached a settlement with Endo Pharmaceuticals Inc. on outstanding patent litigation related to LecTec’s U.S. Patent Nos. 5,536,263 and 5,741,510.

MS Health (NYSE:RX), the world’s leading provider of market intelligence to the pharmaceutical and healthcare industries, announced the upcoming launch of IMS Oncology QuantifierTM, a comprehensive, clinically rich analytical tool that enables the company’s clients to assess treatment opportunities and guide commercial decisions in the $48 billion global oncology market.

NexMed, Inc. (Nasdaq:NEXM), a developer of innovative transdermal products based on the NexACT® drug delivery technology, announced it raised $750,000 in gross proceeds from the issuance of new convertible notes due December 31, 2011 (the “Notes”), which are secured by a mortgage on NexMed’s facility in East Windsor, New Jersey.

Novavax, Inc. (Nasdaq: NVAX) a clinical-stage vaccine company, announced today that John Trizzino, Senior Vice President, International and Government Alliances, will be presenting at the Influenza Congress USA 2009.

Chief Research Officer Morris S. Whitcup, Ph.D., of ORC Guideline (NASDAQ:IUSA) will present findings of the company’s recent research on the impact of social media on fair balance and pharmaceutical marketing at a Food and Drug Administration (FDA) public hearing later this week.

PPD, Inc. (Nasdaq:PPDI) announced its board of directors declared a cash dividend for the fourth quarter of 2009 under its annual cash dividend policy. The quarterly cash dividend will equal $0.15 per share.

Synta Pharmaceuticals Corp. (NASDAQ:SNTA), a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, announced the Company will be presenting at the Lazard Capital Markets 6th Annual Healthcare Conference on Wednesday, November 18 at 10:00 a.m. (ET) at the St. Regis New York.

Tongjitang Chinese Medicines Company (NYSE: TCM), a leading specialty pharmaceutical company focusing on the development, manufacturing, marketing and selling of modernized traditional Chinese medicine in China, announced it plans to announce its third quarter 2009 financial results before the market opens on Wednesday, November 18, 2009.




"Featured Content" profiles are meant to provide awareness of these companies to investors in the small-cap and growth equity community and should not in any way come across as a recommendation to buy, sell or hold these securities. BiomedReports is not paid or compensated by newswires to disseminate or report news and developments about publicly traded companies, but may from time to time receive compensation for advertising, data, analytics and investor relation services from various entities and firms. Full disclosures should be read in the 'About Us Section'.

Add this page to your favorite Social Bookmarking websites
Digg! Reddit! Del.icio.us! Mixx! Google! Live! Facebook! Technorati! StumbleUpon! MySpace! Yahoo!

blog comments powered by Disqus
 

Newsletter